{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:27Z","timestamp":1759333527244},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3928,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1111\/j.0022-202x.2005.23677.x","type":"journal-article","created":{"date-parts":[[2005,2,28]],"date-time":"2005-02-28T11:41:15Z","timestamp":1109590875000},"page":"xx-xxi","source":"Crossref","is-referenced-by-count":18,"title":["Why Is the Mortality of Bullous Pemphigoid Greater in Europe than in the US?"],"prefix":"10.1016","volume":"124","author":[{"given":"Jean-Claude","family":"Bystryn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archderm.1977.01640080045002","article-title":"Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy","volume":"113","author":"Ahmed","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0015","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0022-202X.2004.22504.x","article-title":"Mortality rate of bullous pemphigoid in a US medical center","volume":"122","author":"Colbert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinaminde and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.0022-202X.2005.23628.x","article-title":"Sepsis associated with dermatologic hospitalization is not the cause of high mortatliy of bullous pemphigoid in Europe","volume":"124","author":"Garcia-Doval","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.0022-202X.2005.23626.x","article-title":"Response to mortality rate of a US medical center","volume":"124","author":"Joly","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0040","first-page":"1137","article-title":"Bullous pemphigoid: The latest in diagnosis, prognosis and therapy","volume":"134","author":"Korman","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0050","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23677.x_bb0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0190-9622(92)70085-T","article-title":"Lack of predictive factors for the clinical course of bullous pemphigoid","volume":"26","author":"Venning","year":"1992","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15322041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15322041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T04:03:52Z","timestamp":1548907432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15322041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0022202X15322041"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2005.23677.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}